Consequently, PTB1B inhibitor has the potential to stimulate insulin-regulated glucose uptake, enhance insulin sensitivity, and mitigate insulin resistance, and it is regarded as a promising therapeutic agent for the treatment of diabetes [123]. The gene discussed is INS; the disease is Insulin resistance.